Julie M. Cherrington - 19 Jan 2022 Form 4 Insider Report for Mirati Therapeutics, Inc.

Role
Director
Signature
/s/ Vickie Reed, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
19 Jan 2022
Net transactions value
-$171,203
Form type
4
Filing time
20 Jan 2022, 15:57:28 UTC
Previous filing
18 Jan 2022
Next filing
08 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale $171,203 -1,475 -37% $116.07 2,546 19 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2021.